Over the past twenty-five years, Obesity rates have spiraled to the level nearly 5 hundred million individuals worldwide. The United States leads the world, with a startling 31 % of the population being termed obese.
The medical costs directly associated with obesity are nearly impossible to calculate, simply because multiple health problems and risks are associated with the condition. The preventable health problems associated with obesity include high blood pressure, stroke, heart attack and diabetes.
On the new product front, there is great news. Vivus Pharmaceuticals have recently announced a new weight loss pill, designated for considerable weight loss for obese patients. This groundbreaking medication is named Qsymia, a weight loss pill that was recently approved for prescription by the Food and drug administration.
The significance is that this medication was approved by the FDA this year; while the FDA has been reluctant to approve any weight loss medications in the last ten years. The pills performance has been noteworthy. Qsymia is a combination drug, consisting of two drugs, which are known to have varying degree of effectiveness with obese patients. Together is seems to be quite the combination.
This weight loss drug among other things, is approved under strenuous clinical study. Patients were monitored while on Qsymia for 12 consecutive months. In one study, patients lost an average of 6.7 per cent of body weight, while in the other, patients lost an average of 8.9 per cent. Patients on the highest dosages reported significant body weight loss as high as 22 pounds.
The drugs that make the weight loss pill so effective are Phentermine, an appetite suppressant and Topiramate, an anti-consultant that causes a patient to feel more satisfied after a meal. It is probable that Qsymia is effective because of its two-pronged attack on overeating.
Research also has shown that the continued weight loss helps control other health conditions. Patients and their physicians report over extended use, that blood pressure decreases, and diabetic therapy is significantly reduced. It is also reported that symptoms associated with sleep apnea are lessened.
THe weight loss pill will not be sold over the counter. Qsymia can only be obtained by prescription only. Physicians must be committed to regularly supervising the progress of the patient during the diet; making it one of the safest diet protocols available. It is not advised that pregnant women take it, out of concern for the possibility of birth defects. The drug is restricted to use for adult patients who are clinically diagnosed as obese.
Forward thinking physicians and clinics nationwide have read these studies, and started programs to administer this weapon in the arsenal to fight obesity. The local provider in most areas, Equilibrium Weight Loss and Longevity Clinic, offers the drug in the form of extended-release capsules, as part of their medically supervised weight loss protocol. In the face of epidemic obesity, there is promise on the horizon.
The medical costs directly associated with obesity are nearly impossible to calculate, simply because multiple health problems and risks are associated with the condition. The preventable health problems associated with obesity include high blood pressure, stroke, heart attack and diabetes.
On the new product front, there is great news. Vivus Pharmaceuticals have recently announced a new weight loss pill, designated for considerable weight loss for obese patients. This groundbreaking medication is named Qsymia, a weight loss pill that was recently approved for prescription by the Food and drug administration.
The significance is that this medication was approved by the FDA this year; while the FDA has been reluctant to approve any weight loss medications in the last ten years. The pills performance has been noteworthy. Qsymia is a combination drug, consisting of two drugs, which are known to have varying degree of effectiveness with obese patients. Together is seems to be quite the combination.
This weight loss drug among other things, is approved under strenuous clinical study. Patients were monitored while on Qsymia for 12 consecutive months. In one study, patients lost an average of 6.7 per cent of body weight, while in the other, patients lost an average of 8.9 per cent. Patients on the highest dosages reported significant body weight loss as high as 22 pounds.
The drugs that make the weight loss pill so effective are Phentermine, an appetite suppressant and Topiramate, an anti-consultant that causes a patient to feel more satisfied after a meal. It is probable that Qsymia is effective because of its two-pronged attack on overeating.
Research also has shown that the continued weight loss helps control other health conditions. Patients and their physicians report over extended use, that blood pressure decreases, and diabetic therapy is significantly reduced. It is also reported that symptoms associated with sleep apnea are lessened.
THe weight loss pill will not be sold over the counter. Qsymia can only be obtained by prescription only. Physicians must be committed to regularly supervising the progress of the patient during the diet; making it one of the safest diet protocols available. It is not advised that pregnant women take it, out of concern for the possibility of birth defects. The drug is restricted to use for adult patients who are clinically diagnosed as obese.
Forward thinking physicians and clinics nationwide have read these studies, and started programs to administer this weapon in the arsenal to fight obesity. The local provider in most areas, Equilibrium Weight Loss and Longevity Clinic, offers the drug in the form of extended-release capsules, as part of their medically supervised weight loss protocol. In the face of epidemic obesity, there is promise on the horizon.
About the Author:
If you want to find out if Qsymia diet capsules will be available around you? Most people will need a doctors prescription to get the Qsymia
No comments:
Post a Comment